Cardiovascular system adaptation

Cardiovascular system adaptation is not a specific molecular target, receptor, enzyme, transporter, or other discrete biological entity. Instead, it refers broadly to the collection of structural and functional changes that occur within the cardiovascular system—comprising the heart and blood vessels—in response to various stimuli such as exercise or disease. These adaptations can be physiological (e.g., beneficial cardiac remodeling from endurance training) or pathological (e.g., maladaptive hypertrophy due to hypertension). The underlying mechanisms involve complex signaling pathways—including AMP-dependent protein kinase (AMPK), mitogen activated protein kinases (MAPK), Ca²⁺-dependent pathways, reactive oxygen species signaling—and transcriptional regulators like peroxisome-proliferator-activated receptor gamma coactivator 1-alpha (PGC‑1α). Because "cardiovascular system adaptation" describes a process rather than an individual molecule or druggable target, it does not have canonical names/abbreviations nor direct interacting drugs. It is also not classified under standard molecular families such as receptors or enzymes. Therefore, this entry is incorrect as a therapeutic target, but represents an important area of study for understanding how interventions like exercise impact heart health at both cellular and systemic levels.